Eli Lilly vs Talphera
Eli Lilly (LLY) and Talphera (TLPH) side by side: how big they are, what they earn, how their shares have moved and what insiders, members of Congress and funds reported. Figures from filings and closing prices; none of this is a view on either stock.
- Market value
- $1.27T
- Last close
- $1,347.11
- 12 months
- +29.1%
- Market value
- $40.8M
- Last close
- $0.7852
- 12 months
- −40.1%
At a glance
- The biggest part of Eli Lilly's revenue is Net product revenue, 94% of the total in its last annual report.
- By market value, Eli Lilly ($1.27T) is about 31063 times Talphera ($41M).
- Over the last 12 months Eli Lilly's share price moved +29.1% and Talphera's −40.1%; against the S&P 500 that is +23.4 points and −45.8 points.
- In their last fiscal years Eli Lilly kept 31.7% of revenue as net income and Talphera -51035.7%.
- In the last 90 days insiders reported 0 open-market purchases at Eli Lilly and 0 at Talphera; members of Congress disclosed 4 trades in Eli Lilly and 0 in Talphera.
- Next results: Eli Lilly Feb 2, 2027, Talphera Mar 22, 2027.
How each one makes money: Eli Lilly revenue
Share prices on one chart
Eli Lilly and Talphera, and up to three more you add, drawn on the same scale so you can see which moved more.
Face to face
The figures that separate the two, drawn to the same scale. Every figure is also in the table below.
Size
Market value
Revenue, last fiscal year
Net income, last fiscal year
Every figure
| Eli Lilly LLYNYSE · Pharmaceuticals | Talphera TLPHNASDAQ · Pharmaceutical Preparations | |
|---|---|---|
| Size and profitability | ||
| Market value | $1.27T | $40.8M |
| Revenue, last fiscal year | $65.2B | $28K |
| Net income, last fiscal year | $20.6B | −$14.3M |
| Net marginNet income as a share of revenue | 31.7% | -51035.7% |
| Free cash flow | $16.8B | |
Prices are end-of-day closes, and fundamentals are the companies' last annual figures from their SEC filings: a − or + in the table is a fact of the filing or the close, not a forecast. Market value is the company-level figure at the last close. Counts are of records OQRO holds, by their date; insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned sales under a 10b5-1 plan are counted like other sales.
Compare with another company
Eli Lilly against
Common questions
How is Eli Lilly different from Talphera?
Eli Lilly (LLY) is in Pharmaceuticals on NYSE, with $65.2B of revenue in its last fiscal year and a net margin of 31.7%. Talphera (TLPH) is in Pharmaceutical Preparations on NASDAQ, with $28K of revenue in its last fiscal year and a net margin of -51035.7%. The biggest part of Eli Lilly's revenue is Net product revenue, 94% of the total in its last annual report. The table above sets their figures side by side; it compares filings and is not a view on either stock.
How do Eli Lilly and Talphera compare in size?
Eli Lilly has the larger market value: Eli Lilly $1.27T and Talphera $40.8M, at the last close.
Whose share price rose more over the last 12 months, LLY or TLPH?
Over the last 12 months Eli Lilly moved +29.1% and Talphera −40.1%. Past price moves say nothing about the future.
Which has had more insider buying, Eli Lilly or Talphera?
Since 2006, Talphera insiders reported 98 open-market purchases against 35 for Eli Lilly. These are counts of what was filed, not a view on either stock.
Do members of Congress trade LLY or TLPH?
In the last 12 months, members of Congress disclosed 27 trades in Eli Lilly (LLY) and 0 in Talphera (TLPH).
When did insiders last buy LLY and TLPH?
Eli Lilly: Aug 15, 2025. Talphera: Feb 21, 2026.
See the record behind any of these
A free account opens the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Eli Lilly pageTalphera pageRare insider trades this weekAll comparisons
https://oqro.io/compare/lly-vs-tlph







